216 related articles for article (PubMed ID: 25330857)
1. Lymphovascular invasion is significantly associated with biochemical relapse after radical prostatectomy even in patients with pT2N0 negative resection margin.
Mitsuzuka K; Narita S; Koie T; Kaiho Y; Tsuchiya N; Yoneyama T; Kakoi N; Kawamura S; Tochigi T; Ohyama C; Habuchi T; Arai Y
Prostate Cancer Prostatic Dis; 2015 Mar; 18(1):25-30. PubMed ID: 25330857
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of lymphovascular invasion in radical prostatectomy specimens.
Yee DS; Shariat SF; Lowrance WT; Maschino AC; Savage CJ; Cronin AM; Scardino PT; Eastham JA
BJU Int; 2011 Aug; 108(4):502-7. PubMed ID: 21050364
[TBL] [Abstract][Full Text] [Related]
3. Validation of lymphovascular invasion is an independent prognostic factor for biochemical recurrence after radical prostatectomy.
Fajkovic H; Mathieu R; Lucca I; Hiess M; Hübner N; Al Hussein Al Awamlh B; Lee R; Briganti A; Karakiewicz P; Lotan Y; Roupret M; Rink M; Kluth L; Loidl W; Seitz C; Klatte T; Kramer G; Susani M; Shariat SF
Urol Oncol; 2016 May; 34(5):233.e1-6. PubMed ID: 26973136
[TBL] [Abstract][Full Text] [Related]
4. Significance of perineural invasion, lymphovascular invasion, and high-grade prostatic intraepithelial neoplasia in robot-assisted laparoscopic radical prostatectomy.
Jung JH; Lee JW; Arkoncel FR; Cho NH; Yusoff NA; Kim KJ; Song JM; Kim SJ; Rha KH
Ann Surg Oncol; 2011 Dec; 18(13):3828-32. PubMed ID: 21660497
[TBL] [Abstract][Full Text] [Related]
5. Routinely reported 'equivocal' lymphovascular invasion in prostatectomy specimens is associated with adverse outcomes.
Galiabovitch E; Hovens CM; Peters JS; Costello AJ; Battye S; Norden S; Ryan A; Corcoran NM
BJU Int; 2017 Apr; 119(4):567-572. PubMed ID: 27431748
[TBL] [Abstract][Full Text] [Related]
6. Impact of lymphovascular invasion on lymph node metastasis for patients undergoing radical prostatectomy with negative resection margin.
Kang YJ; Kim HS; Jang WS; Kwon JK; Yoon CY; Lee JY; Cho KS; Ham WS; Choi YD
BMC Cancer; 2017 May; 17(1):321. PubMed ID: 28482884
[TBL] [Abstract][Full Text] [Related]
7. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.
Kupelian PA; Katcher J; Levin HS; Klein EA
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1043-52. PubMed ID: 9169811
[TBL] [Abstract][Full Text] [Related]
8. High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy.
Savdie R; Horvath LG; Benito RP; Rasiah KK; Haynes AM; Chatfield M; Stricker PD; Turner JJ; Delprado W; Henshall SM; Sutherland RL; Kench JG
BJU Int; 2012 Jun; 109(12):1794-800. PubMed ID: 21992536
[TBL] [Abstract][Full Text] [Related]
9. Perineural Invasion and Lymphovascular Invasion are Associated with Increased Risk of Biochemical Recurrence in Patients Undergoing Radical Prostatectomy.
Kang M; Oh JJ; Lee S; Hong SK; Lee SE; Byun SS
Ann Surg Oncol; 2016 Aug; 23(8):2699-706. PubMed ID: 26965702
[TBL] [Abstract][Full Text] [Related]
10. The significance of micro-lymphatic invasion and pathological Gleason score in prostate cancer patients with pathologically organ-confined disease and negative surgical margins after robot-assisted radical prostatectomy.
Hashimoto T; Nakashima J; Inoue R; Komori O; Yamaguchi Y; Kashima T; Satake N; Nakagami Y; Namiki K; Nagao T; Ohno Y
Int J Clin Oncol; 2020 Feb; 25(2):377-383. PubMed ID: 31673831
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of lymphovascular invasion in radical prostatectomy specimens.
May M; Kaufmann O; Hammermann F; Loy V; Siegsmund M
BJU Int; 2007 Mar; 99(3):539-44. PubMed ID: 17155973
[TBL] [Abstract][Full Text] [Related]
12. Lymphovascular invasion in prostate cancer: prognostic significance in patients treated with radiotherapy after radical prostatectomy.
Brooks JP; Albert PS; O'Connell J; McLeod DG; Poggi MM
Cancer; 2006 Apr; 106(7):1521-6. PubMed ID: 16518811
[TBL] [Abstract][Full Text] [Related]
13. Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score.
Freedland SJ; Wieder JA; Jack GS; Dorey F; deKernion JB; Aronson WJ
J Urol; 2002 Jul; 168(1):110-5. PubMed ID: 12050502
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Importance of Lymphovascular Invasion for Specific Subgroup of Patients with Prostate Cancer After Robot-Assisted Radical Prostatectomy (The MSUG94 Group).
Kawase M; Ebara S; Tatenuma T; Sasaki T; Ikehata Y; Nakayama A; Toide M; Yoneda T; Sakaguchi K; Teishima J; Makiyama K; Inoue T; Kitamura H; Saito K; Koga F; Urakami S; Koie T
Ann Surg Oncol; 2024 Mar; 31(3):2154-2162. PubMed ID: 38200385
[TBL] [Abstract][Full Text] [Related]
15. Length of positive surgical margin after radical prostatectomy as a predictor of biochemical recurrence.
Shikanov S; Song J; Royce C; Al-Ahmadie H; Zorn K; Steinberg G; Zagaja G; Shalhav A; Eggener S
J Urol; 2009 Jul; 182(1):139-44. PubMed ID: 19450829
[TBL] [Abstract][Full Text] [Related]
16. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of lymphovascular invasion in clinically localized prostate cancer after radical prostatectomy.
Baydar DE; Baseskioglu B; Ozen H; Geyik PO
ScientificWorldJournal; 2008 Mar; 8():303-12. PubMed ID: 18379707
[TBL] [Abstract][Full Text] [Related]
18. Predictors of biochemical recurrence after Retzius-sparing robot-assisted radical prostatectomy: Analysis of 359 cases with a median follow-up period of 26 months.
Abdel Raheem A; Chang KD; Alenzi MJ; Ham WS; Han WK; Choi YD; Rha KH
Int J Urol; 2018 Dec; 25(12):1006-1014. PubMed ID: 30276864
[TBL] [Abstract][Full Text] [Related]
19. Lymphovascular invasion is an independent predictor of prostate-specific antigen failure after radical prostatectomy in patients with pT3aN0 prostate cancer.
Yamamoto S; Kawakami S; Yonese J; Fujii Y; Ohkubo Y; Suyama T; Komai Y; Kijima T; Ishikawa Y; Fukui I
Int J Urol; 2008 Oct; 15(10):895-9. PubMed ID: 18721204
[TBL] [Abstract][Full Text] [Related]
20. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
